1. National Cancer Institute. About Cancer. Understanding Cancer. [Updated at 2015 Feb 9]. Retrieved at: https://www.cancer.gov/about-cancer/understanding/what-is-cancer. Accessed 2018 July 10
2. American Cancer Society. Cancer Facts and Figures. Estimated Number of New Cancer Cases and Deaths by Sex in the United States. Retrieved at: https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/annual-cancer-facts-and-figures/2018/estimated-number-of-new-cancer-cases-and-deaths-by-sex-us-2018.pdf. Accessed 2018 July 2.
3. B-Cell Lymphomas. National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology. Version 3.2017. Updated 2017 March 27. Retrieved at: https://www.nccn.org/professionals/physician_gls/pdf/b-cell.pdf. Accessed 2018 July 19
4. Fischer K, Cramer P, Busch R, Böttcher S, Bahlo J, Schubert J, Pflüger KH, Schott S, Goede V, Isfort S, von Tresckow J, Fink AM, Bühler A, Winkler D, Kreuzer KA, Staib P, Ritgen M, Kneba M, Döhner H, Eichhorst BF, Hallek M, Stilgenbauer S, Wendtner CM (2012) Bendamustine in combination with rituximab for previously untreated patients with chronic lymphocytic leukemia: a multicenter phase II trial of the German Chronic Lymphocytic Leukemia Study Group. J Clin Oncol 30(26):3209–3216 Epub 2012 Aug 6
5. Kolibaba KS, Sterchele JA, Joshi AD, Forsyth M, Alwon E, Beygi H, Kennealey GT (2013) Demographics, treatment patterns, safety, and real-world effectiveness in patients aged 70 years and over with chronic lymphocytic leukemia receiving bendamustine with or without rituximab: a retrospective study. Ther Adv Hematol 4(3):157–171